These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20571801)

  • 41. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
    Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
    Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostate cancer screening in Tyrol, Austria: experience and results.
    Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
    Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is a sampling transition zone important to increase the detection of prostate cancer in systematic prostatic biopsies?
    Queiroz MR; Falsarella PM; Moreira Valle LG; Cayres Mariotti G; Lemos GC; Alfer Junior W; Garcia RG
    Acta Radiol; 2021 Jun; 62(6):815-820. PubMed ID: 32631078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contrast-enhanced gray-scale transrectal ultrasound-guided prostate biopsy in men with elevated serum prostate-specific antigen levels.
    Yang JC; Tang J; Li J; Luo Y; Li Y; Shi H
    Acad Radiol; 2008 Oct; 15(10):1291-7. PubMed ID: 18790401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
    Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
    Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Value of power doppler and 3D vascular sonography as a method for diagnosis and staging of prostate cancer.
    Sauvain JL; Palascak P; Bourscheid D; Chabi C; Atassi A; Bremon JM; Palascak R
    Eur Urol; 2003 Jul; 44(1):21-30; discussion 30-1. PubMed ID: 12814671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcome of transrectal ultrasound-guided prostate biopsy, targeting eight cores, for detecting prostate cancer in Japanese men.
    Ishimura T; Sakai I; Hara I; Eto H; Miyake H
    Int J Clin Oncol; 2004 Feb; 9(1):47-50. PubMed ID: 15162826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Status of transrectal ultrasound imaging of the prostate.
    Aigner F; Mitterberger M; Rehder P; Pallwein L; Junker D; Horninger W; Frauscher F
    J Endourol; 2010 May; 24(5):685-91. PubMed ID: 20433367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostate: high-frequency Doppler US imaging for cancer detection.
    Halpern EJ; Frauscher F; Strup SE; Nazarian LN; O'Kane P; Gomella LG
    Radiology; 2002 Oct; 225(1):71-7. PubMed ID: 12354987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection.
    Haffner J; Lemaitre L; Puech P; Haber GP; Leroy X; Jones JS; Villers A
    BJU Int; 2011 Oct; 108(8 Pt 2):E171-8. PubMed ID: 21426475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers.
    Kuligowska E; Barish MA; Fenlon HM; Blake M
    Radiology; 2001 Sep; 220(3):757-64. PubMed ID: 11526279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?
    Remzi M; Dobrovits M; Reissigl A; Ravery V; Waldert M; Wiunig C; Fong YK; Djavan B;
    Eur Urol; 2004 Oct; 46(4):451-6. PubMed ID: 15363559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance.
    Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accuracy of real-time magnetic resonance imaging-transrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical position-encoded stepper in detecting significant prostate cancer in biopsy-naïve men.
    Shoji S; Hiraiwa S; Ogawa T; Kawakami M; Nakano M; Hashida K; Sato Y; Hasebe T; Uchida T; Tajiri T
    Int J Urol; 2017 Apr; 24(4):288-294. PubMed ID: 28222486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Can indexes based on PSA determine which patients should undergo repeated ultrasound-guided transrectal prostatic biopsy? Study on 546 patients who underwent repeated biopsy].
    Rodríguez-Patrón Rodríguez R; Mayayo Dehesa T; González Galán A; Zuccarino AL; García González R; Cuesta Roca C
    Arch Esp Urol; 2002 Dec; 55(10):225-34. PubMed ID: 12611220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Role of Ipsilateral and Contralateral Transrectal Ultrasound-guided Systematic Prostate Biopsy in Men With Unilateral Magnetic Resonance Imaging Lesion Undergoing Magnetic Resonance Imaging-ultrasound Fusion-targeted Prostate Biopsy.
    Bryk DJ; Llukani E; Taneja SS; Rosenkrantz AB; Huang WC; Lepor H
    Urology; 2017 Apr; 102():178-182. PubMed ID: 27871829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Additional value of magnetic resonance-targeted biopsies to standard transrectal ultrasound-guided biopsies for detection of clinically significant prostate cancer.
    von Below C; Wassberg C; Norberg M; Tolf A; Kullberg J; Ladjevardi S; Häggman M; Bill Axelson A; Ahlström H
    Scand J Urol; 2017 Apr; 51(2):107-113. PubMed ID: 28635568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
    Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
    Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contrast-enhanced ultrasound versus color duplex ultrasound imaging in the follow-up of patients after endovascular abdominal aortic aneurysm repair.
    Iezzi R; Basilico R; Giancristofaro D; Pascali D; Cotroneo AR; Storto ML
    J Vasc Surg; 2009 Mar; 49(3):552-60. PubMed ID: 19135839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimizing the Number of Cores Targeted During Prostate Magnetic Resonance Imaging Fusion Target Biopsy.
    Kenigsberg AP; Renson A; Rosenkrantz AB; Huang R; Wysock JS; Taneja SS; Bjurlin MA
    Eur Urol Oncol; 2018 Oct; 1(5):418-425. PubMed ID: 31158081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.